References
- Koçak U, Gürsel T, Oztiirk G, Kantarci S. Thrombous during all-trans-retinoic acid therapy in a child with acute promyelocytic leukemia and factor VQ 506 mutation. Pediatr Hematol Oncol. 2000;17:177–180.
- Hiçsônmez G, Ozsoylu 5, Gargey A, Zamani VP, irken G. High dose methylprednisolone for remission induction in children with acute nonlymphoblastic leukemia. Eur J Haematol. 1989;42:498–500.
- Hiçsônmez G, Ozsoylu 5, Tuncer M. Direct morphological evidence of high dose methylprednisolone induced maturation of leukemia cells in children with acute nonlymphoblastic leukemia. Exp Hematol. 1994;19:232–233.
- Hiçsônmez G, Ozsoylu 5, Tuncer M, Ertiirk G, Ozbek N, Karadeniz N. Differentiation in patients with acute myeloblastic leukemia and its therapeutic potential. Leuk Res. 1991;15:537–541.
- Bernini JC, Carrillo JM, Buchanan GR. High-dose intravenous methylprednisolone therapy for patients with Diamond—Blackfan anemia refractory to conventional doses of prednisone. J Pediam 1995;127: 654–659.
- Ozsoylu S. High dose intravenous methylprednisolone (HIVMP) in haematologic disorders. Hematol Rev. 1990;4:197–207.